Alpine Immune Sciences (ALPN) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free ALPN Stock Alerts $64.60 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAlpine Immune Sciences Incmorningstar.com - May 1 at 9:06 PMAlpine Immune Sciences (NASDAQ:ALPN) Sets New 1-Year High at $64.70marketbeat.com - April 29 at 5:50 PMAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Short Interest Down 10.2% in Aprilamericanbankingnews.com - April 29 at 3:44 AMVivo Capital LLC Sells 298,770 Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN)marketbeat.com - April 27 at 9:40 PMLatest News for Alpine Immune Sciences Stock (NASDAQ:ALPN)benzinga.com - April 27 at 11:06 AMALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune ...businesswire.com - April 27 at 1:05 AMALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPNbusinesswire.com - April 26 at 4:13 PMAlpine Immune Sciences, Inc. (ALPN)finance.yahoo.com - April 23 at 7:45 AMAlpine Immune Sciences (NASDAQ:ALPN) Sets New 1-Year High at $64.58marketbeat.com - April 22 at 7:38 PMAlpine Immune Sciences (NASDAQ:ALPN) Sees Large Volume Increasemarketbeat.com - April 19 at 11:58 AMTD Cowen Downgrades Alpine Immune Sciences (ALPN)msn.com - April 18 at 7:07 PMINVESTIGATION: The M&A Class Action Firm Announces an Investigation of Alpine Immune Sciences, Inc. - ALPNprnewswire.com - April 17 at 7:50 PMAlpine Immune Sciences (ALPN) Price Target Increased by 36.91% to 63.24msn.com - April 17 at 8:23 AMAlpine Immune Sciences (NASDAQ:ALPN) Given "Hold" Rating at TD Cowenmarketbeat.com - April 16 at 8:19 AMCan You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024?investorplace.com - April 15 at 3:43 PMAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Bought by Vanguard Group Inc.marketbeat.com - April 15 at 4:15 AMAlpine Immune Sciences (NASDAQ:ALPN) Downgraded by Leerink Partnrs to Market Performmarketbeat.com - April 13 at 7:56 AMCould This Stock Be the Next Biotech Buyout?fool.com - April 13 at 5:29 AMSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Alpine Immune Sciences, Inc. Buyoutstockhouse.com - April 12 at 5:44 PMALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPNbusinesswire.com - April 12 at 5:17 PMAlpine Immune Sciences' (ALPN) "Market Perform" Rating Reaffirmed at SVB Leerinkmarketbeat.com - April 12 at 10:22 AMAlpine Immune Sciences (NASDAQ:ALPN) Downgraded by HC Wainwrightmarketbeat.com - April 12 at 5:59 AMThese Stocks Moved the Most Today: CarMax, Apple, Fastenal, Rivian, Alpine Immune, Nike, Robinhood, Constellation Brands, and Morefinance.yahoo.com - April 11 at 5:53 PMVertex To Buy Alpine Immune - Why This Deal Feels Slightly 'Vanilla'seekingalpha.com - April 11 at 12:52 PMVertex Pharmaceuticals to Buy Alpine Immune in $4.9B Dealbarrons.com - April 11 at 10:46 AMAlpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy Itinvestors.com - April 11 at 10:36 AMThe $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Todayinvestorplace.com - April 11 at 9:47 AMAlpine Immune Sciences' (ALPN) "Neutral" Rating Reaffirmed at Wedbushmarketbeat.com - April 11 at 8:31 AMAlpine Immune Sciences soars on $4.9bn Vertex takeoverproactiveinvestors.com - April 11 at 7:16 AMVertex Stock in Focus After Deal to Buy Alpine Immune For $4.9B—Key Level to Watchinvestopedia.com - April 10 at 10:45 PMShareholder Alert: Ademi LLP investigates whether Alpine Immune Sciences, Inc. has obtained a Fair Price in its transaction with Vertexprnewswire.com - April 10 at 9:50 PMALPN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alpine Immune Sciences, Inc. Is Fair to Shareholdersbusinesswire.com - April 10 at 8:08 PMVertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Dealinvestors.com - April 10 at 4:45 PMVertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 blnreuters.com - April 10 at 4:20 PMmarketbeat.com - April 10 at 4:16 PMAlpine Immune Is Weighing Options After Takeover Interestbloomberg.com - April 10 at 4:15 PMWhy Is Kidney Disease-Focused Alpine Immune Sciences Stock Trading Higher On Wednesday?benzinga.com - April 10 at 4:15 PMAlpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathybusinesswire.com - April 10 at 4:15 PMVertex Enters Into Agreement to Acquire Alpine Immune Sciencesbusinesswire.com - April 10 at 4:01 PMVertex Enters Into Agreement to Acquire Alpine Immune Sciencesbusinesswire.com - April 10 at 4:01 PMAlpine Immune Sciences (NASDAQ:ALPN) Sets New 12-Month High at $45.44marketbeat.com - April 10 at 3:24 PMmarketbeat.com - April 10 at 12:38 PMNavigating 8 Analyst Ratings For Alpine Immune Sciencesmarkets.businessinsider.com - April 9 at 12:26 PMGuggenheim Begins Coverage on Alpine Immune Sciences (NASDAQ:ALPN)marketbeat.com - April 9 at 8:24 AMAlpine Immune Sciences (NASDAQ:ALPN) Trading Up 6.8%marketbeat.com - April 8 at 11:38 AMAlpine Immune Sciences (NASDAQ:ALPN) Shares Down 5.6% marketbeat.com - April 3 at 4:50 PMAlpine Immune Sciences to Present Updated Clinical Data for Povetacicept in IgA Nephropathy at the World Congress of Nephrology 2024finance.yahoo.com - April 1 at 5:21 PMAlpine Immune Sciences (NASDAQ:ALPN) Shares Up 6.3%marketbeat.com - March 21 at 5:42 PMAlpine Immune Sciences, Inc.: Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024finanznachrichten.de - March 21 at 9:23 AMBuy Rating Affirmed for Alpine Immune Sciences Amid Positive Povetacicept Trials and Strong Clinical Outlookmarkets.businessinsider.com - March 21 at 9:23 AM Get Alpine Immune Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALPN and its competitors with MarketBeat's FREE daily newsletter. Email Address The asset beating inflation by 4x (Ad)"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties. That's why we have released our Free Precious Metals Investment Guide that explains all the details ALPN Media Mentions By Week ALPN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALPN News Sentiment▼0.730.43▲Average Medical News Sentiment ALPN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALPN Articles This Week▼63▲ALPN Articles Average Week Get Alpine Immune Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALPN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALKS News MDGL News NUVL News PRGO News CBAY News OGN News BBIO News INSM News PBH News RARE News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALPN) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe Gold Grab of the CenturyColonial Metals4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpine Immune Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
